arrow
P

Priscilla K. Brastianos

mass general brigham cancer institute
H指数:76
被引数:2.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combination treatment with RAF/MEK inhibitor avutometinib and FAK inhibitor defactinib in preclinical models of meningioma

与 RAF/MEK 抑制剂阿伏美替尼和 FAK 抑制剂德法替尼联合治疗脑膜瘤的预临床模型

2026-08-120
OA
PACM-04 ONCOLYTIC ADENOVIRUS RGDOX INDUCES SYSTEMIC CD8+ T CELL–MEDIATED IMMUNITY ACROSS INTRACRANIAL MELANOMA METASTASES: RATIONALE FOR A PHASE I TRIAL

PACM-04 溶瘤腺病毒RGDOX在颅内黑色素瘤转移中诱导系统性CD8+ T细胞介导的免疫反应:I期临床试验的依据

2026-08-070
OA
RTAD-03 THE ROLE OF RADIOTHERAPY IN RESECTED NON-SMALL CELL LUNG CANCER BRAIN METASTASES TREATED WITH CNS-ACTIVE TYROSINE KINASE INHIBITORS

RTAD-03 放射疗法在治疗接受中枢神经系统活性酪氨酸激酶抑制剂治疗的切除非小细胞肺癌脑转移灶中的作用

2026-08-070
OA
Covalent pan-TEAD inhibitors block YAP activity and demonstrate brain penetrance in a Hippo-dependent cancer model

共价泛TEAD抑制剂阻断YAP活性,并在Hippo依赖性癌症模型中表现出脑渗透性

2026-06-270
OAAI
Integrating multimodal management and molecular profiling in a patient with BRAF V600E–positive melanoma and brain metastases

整合多模态管理与分子分型在BRAF V600E阳性黑色素瘤伴脑转移患者中的应用

2026-03-260
OAAI
Abemaciclib in meningiomas with somatic NF2 or CDK pathway alterations: the phase 2 Alliance A071401 trial

Abemaciclib在具有体细胞NF2或CDK途径改变的脑膜瘤中的应用: 2期联盟A071401试验

2026-01-160
OAAI
Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastases

新型治疗策略及乳腺癌合并中枢神经系统(CNS)转移患者的关键研究重点

2025-12-200
OAAI
An opportune time for targeted brain arteriovenous malformation therapy

靶向脑动静脉畸形治疗的有利时机

2025-12-010
PRE
Molecular landscape and clinical correlates of olfactory groove meningiomas: a multi-institutional study

嗅沟脑膜瘤的分子图谱及临床相关性:一项多中心研究

2025-12-010
PRE
Microbial signals in primary and metastatic brain tumors

原发性和转移性脑肿瘤中的微生物信号

2025-11-140
OAAI
Reflecting on scientific growth and innovation as the Society for Neuro-Oncology turns 30

在神经肿瘤学会成立30周年之际,回顾科学增长与创新

2025-11-040
PRE
ALLIANCE A071601: PHASE II TRIAL OF BRAF/MEK INHIBITION IN RECURRENT PAPILLARY CRANIOPHARYNGIOMAS

联盟A071601:BRAF/MEK抑制在复发性乳头状颅咽管瘤中的II期试验

2025-11-010
PRE
The oncolytic adenovirus RGDOX sensitizes the anti-tumor efficacy of immune checkpoint blockades in murine melanoma brain metastases models

溶瘤腺病毒RGDOX增强免疫检查点阻断在鼠黑色素瘤脑转移模型中的抗肿瘤疗效

2025-11-010
OAAI
Integrated multiomic profiling identifies genomic and immune microenvironmental changes as candidate resistance mechanisms to PD-1 blockade in high-grade meningiomas

整合多组学分析鉴定出基因组改变和免疫微环境变化为高级别脑膜瘤对PD-1阻断治疗的候选耐药机制

2025-11-010
OAAI